<p>Ocular Metastasis in Elderly Lung Cancer Patients: Potential Risk Factors of CA-125, CA-153 and TPSA</p>
نویسندگان
چکیده
منابع مشابه
CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma
OBJECTIVES Among patients who underwent primary surgery for non-small cell lung cancer (NSCLC), recurrent disease is frequent and cannot be accurately predicted solely from TNM stage and histopathological features. The aim of this study was to examine the association of tumor markers in pre-operative serum with recurrent disease. MATERIAL AND METHODS Blood samples were collected prior to lung...
متن کاملSerum CA 125 and ovarian cancer
of death from gynaecological cancer among women in Western countries. Epithelial ovarian cancer is responsible for 85-90% of all primary ovarian tumours. Because of the asymptomatic nature of the disease, ovarian cancer is usually not detected in the early stages and therefore many women present with advanced disease and systemic metastases. Approximately 70-80% of patients present with late st...
متن کاملUnderstanding CA 125 Levels A GUIDE FOR OVARIAN CANCER PATIENTS
The Foundation for Women's Cancer, formerly the Gynecologic Cancer Foundation, was established by the Society of Gynecologic Oncology in 1991 to increase funding for research and training, and to develop educational and awareness programs for women. These programs focus on the prevention, early detection and optimal treatment of gynecologic cancers. As a 501(c)(3) not-for-profit charitable orga...
متن کاملDiagnostic values of serum TRACP5b, CEA and CA-153 in predicting bone metastasis in lymph node-negative breast cancer patients
Objective: To evaluate the clinical significance of serum levels of Tartrate Resistant Acid Phosphatase 5b (TRACP5b), Carcino-Embryonic Antigen (CEA) and CA-153 in predicting the bone metastasis in patients diagnosed with lymph node-negative breast cancer. Methods: Seventy-seven patients pathologically diagnosed with lymph node-negative breast cancer were recruited in the breast cancer group an...
متن کاملElevation of CA 125 and CA 19-9 in patients with end-stage liver disease.
BACKGROUND The serum tumor markers CA 19-9 and CA 125 are the serologic markers used for the monitoring of biliopancreatic and ovarian cancer, respectively. They are reported to be elevated in a variety of nonneoplastic clinical situations, including end-stage liver disease (ESLD). However, their prevalence and degree of elevation in patients with ESLD remained unclear. AIM To examine the pre...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer Management and Research
سال: 2020
ISSN: 1179-1322
DOI: 10.2147/cmar.s232734